Y14 positively regulates TNF-α-induced NF-kB transcriptional activity via interacting RIP1 and TRADD beyond an exon junction complex protein

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1436-1444

  Togi, Sumihito ^a   Shiga, Kaname ^a   Muromoto, Ryuta ^a   Kato, Masaya ^a   Souma, Yuki ^a   Sekine, Yuichi ^a   Kon, Shigeyuki ^a   Oritani, Kenji ^b   Matsuda, Tadashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EXON JUNCTION COMPLEX PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; RIP1 PROTEIN; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED DEATH DOMAIN PROTEIN; UNCLASSIFIED DRUG; Y14 PROTEIN;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; EMBRYO; EXON; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

CELL LINE, TUMOR; HEK293 CELLS; HELA CELLS; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-6; NF-KAPPA B; NUCLEAR PORE COMPLEX PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TNF RECEPTOR-ASSOCIATED DEATH DOMAIN PROTEIN; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84880668643     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300501     Document Type: Article

References (37)

1. Chen, G., and D. V. Goeddel. 2002. TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
2. Aggarwal, B. B. 2003. Signalling pathways of the TNF superfamily: a doubleedged sword. Nat. Rev. Immunol. 3: 745-756.
3. Oeckinghaus, A., M. S. Hayden, and S. Ghosh. 2011. Crosstalk in NF-kB signaling pathways. Nat. Immunol. 12: 695-708.
4. Feldmann, M., R. N. Maini, J. Bondeson, P. Taylor, B. M. Foxwell, and F. M. Brennan. 2001. Cytokine blockade in rheumatoid arthritis. Adv. Exp. Med. Biol. 490: 119-127.
5. Reimold, A. M. 2002. TNFalpha as therapeutic target: new drugs, more applications. Curr. Drug Targets Inflamm. Allergy 1: 377-392.
6. Feldmann, M., F. M. Brennan, B. M. Foxwell, P. C. Taylor, R. O. Williams, and R. N. Maini. 2005. Anti-TNF therapy: where have we got to in 2005? J. Autoimmun. 25(Suppl.): 26-28.
7. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
8. Baud, V., and M. Karin. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11: 372-377.
9. Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5: 392-401.
10. Ben-Neriah, Y., and M. Karin. 2011. Inflammation meets cancer, with NF-kB as the matchmaker. Nat. Immunol. 12: 715-723.
11. Kamitani, S., S. Togi, O. Ikeda, M. Nakasuji, A. Sakauchi, Y. Sekine, R. Muromoto, K. Oritani, and T. Matsuda. 2011. Krüppel-Associated boxassociated protein 1 negatively regulates TNF-A-induced NF-kB transcriptional activity by influencing the interactions among STAT3, p300, and NF-kB/p65. J. Immunol. 187: 2476-2483.
12. Lee, H., A. Herrmann, J. H. Deng, M. Kujawski, G. Niu, Z. Li, S. Forman, R. Jove, D. M. Pardoll, and H. Yu. 2009. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15: 283-293.
13. Kataoka, N., J. Yong, V. N. Kim, F. Velazquez, R. A. Perkinson, F. Wang, and G. Dreyfuss. 2000. Pre-mRNA splicing imprints mRNA in the nucleus with a novel RNA-binding protein that persists in the cytoplasm. Mol. Cell 6: 673-682.
14. Kim, V. N., J. Yong, N. Kataoka, L. Abel, M. D. Diem, and G. Dreyfuss. 2001. The Y14 protein communicates to the cytoplasm the position of exon-exon junctions. EMBO J. 20: 2062-2068.
15. Palacios, I. M. 2002. RNA processing: splicing and the cytoplasmic localisation of mRNA. Curr. Biol. 12: R50-R52.
16. Chang, Y. F., J. S. Imam, and M. F. Wilkinson. 2007. The nonsense-mediated decay RNA surveillance pathway. Annu. Rev. Biochem. 76: 51-74.
17. Hachet, O., and A. Ephrussi. 2001. Drosophila Y14 shuttles to the posterior of the oocyte and is required for oskar mRNA transport. Curr. Biol. 11: 1666-1674.
18. Hachet, O., and A. Ephrussi. 2004. Splicing of oskar RNA in the nucleus is coupled to its cytoplasmic localization. Nature 428: 959-963.
19. Kataoka, N., M. D. Diem, V. N. Kim, J. Yong, and G. Dreyfuss. 2001. Magoh, a human homolog of Drosophila mago nashi protein, is a component of the splicing-dependent exon-exon junction complex. EMBO J. 20: 6424-6433.
20. Ohbayashi, N., N. Taira, S. Kawakami, S. Togi, N. Sato, O. Ikeda, S. Kamitani, R. Muromoto, Y. Sekine, and T. Matsuda. 2008. An RNA biding protein, Y14 interacts with and modulates STAT3 activation. Biochem. Biophys. Res. Commun. 372: 475-479.
21. Muromoto, R., N. Taira, O. Ikeda, K. Shiga, S. Kamitani, S. Togi, S. Kawakami, Y. Sekine, A. Nanbo, K. Oritani, and T. Matsuda. 2009. The exon-junction complex proteins, Y14 and MAGOH regulate STAT3 activation. Biochem. Biophys. Res. Commun. 382: 63-68.
22. Sekine, Y., T. Yumioka, T. Yamamoto, R. Muromoto, S. Imoto, K. Sugiyma, K. Oritani, K. Shimoda, M. Minoguchi, S. Akira, et al. 2006. Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages. J. Immunol. 176: 380-389.
23. Watanabe, N., T. Iwamura, T. Shinoda, and T. Fujita. 1997. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation. EMBO J. 16: 3609-3620.
24. Fujita, T., G. P. Nolan, S. Ghosh, and D. Baltimore. 1992. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev. 6: 775-787.
25. Sakurai, H., H. Miyoshi, W. Toriumi, and T. Sugita. 1999. Functional interactions of transforming growth factor beta-Activated kinase 1 with IkappaB kinases to stimulate NF-kappaB activation. J. Biol. Chem. 274: 10641-10648.
26. Togi, S., O. Ikeda, S. Kamitani, M. Nakasuji, Y. Sekine, R. Muromoto, A. Nanbo, K. Oritani, T. Kawai, S. Akira, and T. Matsuda. 2011. Zipperinteracting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4). J. Biol. Chem. 286: 19170-19177.
27. Ikeda, O., Y. Sekine, T. Yasui, K. Oritani, K. Sugiyma, R. Muromoto, N. Ohbayashi, A. Yoshimura, and T. Matsuda. 2008. STAP-2 negatively regulates both canonical and noncanonical NF-kappaB activation induced by Epstein-Barr virus-derived latent membrane protein 1. Mol. Cell. Biol. 28: 5027-5042.
28. Matsuda, T., T. Yamamoto, A. Muraguchi, and F. Saatcioglu. 2001. Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J. Biol. Chem. 276: 42908-42914.
29. Muromoto, R., M. Ishida, K. Sugiyama, Y. Sekine, K. Oritani, K. Shimoda, and T. Matsuda. 2006. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation. J. Immunol. 177: 1160-1170.
30. Guo, D., J. D. Dunbar, C. H. Yang, L. M. Pfeffer, and D. B. Donner. 1998. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J. Immunol. 160: 2742-2750.
31. Pincheira, R., A. F. Castro, O. N. Ozes, P. S. Idumalla, and D. B. Donner. 2008. Type 1 TNF receptor forms a complex with and uses Jak2 and c-Src to selectively engage signaling pathways that regulate transcription factor activity. J. Immunol. 181: 1288-1298.
32. Miscia, S., M. Marchisio, A. Grilli, V. Di Valerio, L. Centurione, G. Sabatino, F. Garaci, G. Zauli, E. Bonvini, and A. Di Baldassarre. 2002. Tumor necrosis factor alpha (TNF-Alpha) activates Jak1/Stat3-Stat5B signaling through TNFR-1 in human B cells. Cell Growth Differ. 13: 13-18.
33. Ghosh, S., and M. S. Hayden. 2008. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 8: 837-848.
34. Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2: 301-310.
35. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16: 225-260.
36. Azijli, K., S. Yuvaraj, M. P. Peppelenbosch, T. Würdinger, H. Dekker, J. Joore, E. van Dijk, W. J. Quax, G. J. Peters, S. de Jong, and F. A. Kruyt. 2012. Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells. J. Cell Sci. 125: 4651-4661.
37. Shulga, N., and J. G. Pastorino. 2012. GRIM-19-mediated translocation of STAT3 to mitochondria is necessary for TNF-induced necroptosis. J. Cell Sci. 125: 2995-3003.